FINWIRES · TerminalLIVE
FINWIRES

Elixir Energy Front-Runner in Queensland-Based Taroom Trough, Says Euroz Hartleys

-- Elixir Energy (ASX:EXR) is a key pick to tap the potential of the Taroom Trough, an emerging onshore oil and gas basin in Queensland that is gaining mainstream attention, Euroz Hartleys said Monday in a note.

Queensland Premier David Crisafulli last week led federal officials on a visit to the Taroom Trough with operators including Elixir Energy to highlight the basin's potential as a source of energy security.

Elixir, much like the oil giant Shell, which is steering the commercialization of the basin, commenced feasibility work on Friday with APA Group (ASX:APA) on a pipeline linking potential Taroom Trough gas production to the Wallumbilla Gas Hub, improving access to domestic and export markets. Early drilling results from these companies are suggesting encouraging resource potential.

Euroz Hartleys is betting on Elixir as the company trades at about half the valuation of basin peer Omega Oil and Gas (ASX:OMA) despite holding the largest net acreage and resource position in the Taroom. Additionally, Elixir holds a 50% stake in the Diona well, a side project close to the Taroom, which could support small-scale and near-term production if testing is successful.

Euroz Hartleys maintained its speculative buy rating on Elixir Energy and raised its price target to AU$0.28 from AU$0.19.

相关文章

Asia

Dizal Pharma将在美国临床肿瘤学会年会上公布三种药物的研究成果。

据周三在上海证券交易所发布的公告显示,江苏迪扎尔制药(SHA:688192)表示,将在美国临床肿瘤学会(ASCO)年会上公布其新药sunvozertinib片剂、golidocitinib胶囊和DZD6008的最新研究成果。 sunvozertinib和DZD6008均用于治疗非小细胞肺癌,而golidocitinib则用于治疗T细胞淋巴瘤。研究结果显示,这些药物均取得了积极成果,尤其是DZD6008,其具有显著的抗肿瘤活性且安全性良好。 该生物技术公司的股价在午盘交易中上涨不到2%。

$SHA:688192
Asia

Critica将于3月季度启动西澳大利亚稀土项目范围界定研究。

据周三提交给澳大利亚证券交易所的文件显示,Critica(ASX:CRI)表示,位于西澳大利亚的Jupiter稀土项目的初步研究已于今年3月季度正式启动。 该研究整合了选矿、下游加工、基础设施和开发假设,旨在确定一个基准开发路径。 公司计划在6月季度继续完成Jupiter项目140个钻孔的资源升级钻探工作。此外,公司还计划准备并运送20,000公斤散装样品进行中试规模处理,以支持持续的优化、性能提升和中间精矿的生产。

$ASX:CRI
Asia

北太平洋银行的收购要约确保了对卡里尔银行的控制权

北太平洋银行(东京证券交易所代码:8524)周三在东京证券交易所发布公告称,其对Career Bank的股份收购要约已获成功,持股比例增至88.26%,使Career Bank成为其子公司。 北太平洋银行此次收购了852,487股Career Bank股份,超过了完成交易所需的最低收购数量。 结算将于4月28日开始,届时Career Bank将正式并入北太平洋银行的财务报表。 北太平洋银行计划启动相关程序,使Career Bank成为其全资子公司,并将其股票从札幌证券交易所退市。此次收购总成本约为15亿日元。

$TYO:8524